Literature DB >> 28409250

Gadolinium-based contrast agents in pediatric magnetic resonance imaging.

Eric M Gale1, Peter Caravan1, Anil G Rao2, Robert J McDonald3, Matthew Winfeld4, Robert J Fleck5, Michael S Gee6.   

Abstract

Gadolinium-based contrast agents can increase the accuracy and expediency of an MRI examination. However the benefits of a contrast-enhanced scan must be carefully weighed against the well-documented risks associated with administration of exogenous contrast media. The purpose of this review is to discuss commercially available gadolinium-based contrast agents (GBCAs) in the context of pediatric radiology. We discuss the chemistry, regulatory status, safety and clinical applications, with particular emphasis on imaging of the blood vessels, heart, hepatobiliary tree and central nervous system. We also discuss non-GBCA MRI contrast agents that are less frequently used or not commercially available.

Entities:  

Keywords:  Children; Contrast agent; Gadolinium-based contrast agent; Magnetic resonance imaging; Safety

Mesh:

Substances:

Year:  2017        PMID: 28409250     DOI: 10.1007/s00247-017-3806-0

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  100 in total

1.  Magnetic resonance imaging evaluation of myocardial perfusion and viability in congenital and acquired pediatric heart disease.

Authors:  Ashwin Prakash; Andrew J Powell; Rajesh Krishnamurthy; Tal Geva
Journal:  Am J Cardiol       Date:  2004-03-01       Impact factor: 2.778

Review 2.  Non-contrast enhanced MR angiography: established techniques.

Authors:  Mitsue Miyazaki; Masaaki Akahane
Journal:  J Magn Reson Imaging       Date:  2012-01       Impact factor: 4.813

Review 3.  Chemical exchange saturation transfer contrast agents for magnetic resonance imaging.

Authors:  A Dean Sherry; Mark Woods
Journal:  Annu Rev Biomed Eng       Date:  2008       Impact factor: 9.590

Review 4.  In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticles.

Authors:  Hamed Arami; Amit Khandhar; Denny Liggitt; Kannan M Krishnan
Journal:  Chem Soc Rev       Date:  2015-09-21       Impact factor: 54.564

5.  Vascular Imaging With Ferumoxytol as a Contrast Agent.

Authors:  Michael D Hope; Thomas A Hope; Chengcheng Zhu; Farshid Faraji; Henrik Haraldsson; Karen G Ordovas; David Saloner
Journal:  AJR Am J Roentgenol       Date:  2015-06-23       Impact factor: 3.959

6.  Gadolinium-based Contrast Agent Accumulates in the Brain Even in Subjects without Severe Renal Dysfunction: Evaluation of Autopsy Brain Specimens with Inductively Coupled Plasma Mass Spectroscopy.

Authors:  Tomonori Kanda; Toshio Fukusato; Megumi Matsuda; Keiko Toyoda; Hiroshi Oba; Jun'ichi Kotoku; Takahiro Haruyama; Kazuhiro Kitajima; Shigeru Furui
Journal:  Radiology       Date:  2015-05-05       Impact factor: 11.105

7.  High-throughput screening of chemical exchange saturation transfer MR contrast agents.

Authors:  Guanshu Liu; Assaf A Gilad; Jeff W M Bulte; Peter C M van Zijl; Michael T McMahon
Journal:  Contrast Media Mol Imaging       Date:  2010 May-Jun       Impact factor: 3.161

8.  Macrocyclic and Other Non-Group 1 Gadolinium Contrast Agents Deposit Low Levels of Gadolinium in Brain and Bone Tissue: Preliminary Results From 9 Patients With Normal Renal Function.

Authors:  Nozomu Murata; Luis F Gonzalez-Cuyar; Kiyoko Murata; Corinne Fligner; Russell Dills; Daniel Hippe; Kenneth R Maravilla
Journal:  Invest Radiol       Date:  2016-07       Impact factor: 6.016

9.  Dual contrast perfusion MRI in a single imaging session for assessment of pediatric brain tumors.

Authors:  Eric M Thompson; Daniel J Guillaume; Edit Dósa; Xin Li; Kellie J Nazemi; Seymur Gahramanov; Bronwyn E Hamilton; Edward A Neuwelt
Journal:  J Neurooncol       Date:  2012-04-19       Impact factor: 4.130

10.  Regional mapping of gas uptake by blood and tissue in the human lung using hyperpolarized xenon-129 MRI.

Authors:  Kun Qing; Kai Ruppert; Yun Jiang; Jaime F Mata; G Wilson Miller; Y Michael Shim; Chengbo Wang; Iulian C Ruset; F William Hersman; Talissa A Altes; John P Mugler
Journal:  J Magn Reson Imaging       Date:  2013-05-16       Impact factor: 4.813

View more
  17 in total

1.  Half-dose versus full-dose macrocyclic gadolinium at 3-T magnetic resonance imaging in paediatric bone and soft-tissue disease.

Authors:  Giovanna Stefania Colafati; Enrica Rossi; Chiara Carducci; Simone Piga; Ioan Paul Voicu; Angela Mastronuzzi; Paolo Tomà
Journal:  Pediatr Radiol       Date:  2018-07-25

Review 2.  Gadolinium-based contrast agents - review of recent literature on magnetic resonance imaging signal intensity changes and tissue deposits, with emphasis on pediatric patients.

Authors:  Einat Blumfield; David W Swenson; Ramesh S Iyer; A Luana Stanescu
Journal:  Pediatr Radiol       Date:  2019-03-29

Review 3.  Intravenous gadolinium-based hepatocyte-specific contrast agents (HSCAs) for contrast-enhanced liver magnetic resonance imaging in pediatric patients: what the radiologist should know.

Authors:  Rama S Ayyala; Sudha A Anupindi; Michael S Gee; Andrew T Trout; Michael J Callahan
Journal:  Pediatr Radiol       Date:  2019-07-26

4.  Surveillance magnetic resonance imaging for isolated optic pathway gliomas: is gadolinium necessary?

Authors:  Ezekiel Maloney; A Luana Stanescu; Francisco A Perez; Ramesh S Iyer; Randolph K Otto; Sarah Leary; Lotte Steuten; Amanda I Phipps; Dennis W W Shaw
Journal:  Pediatr Radiol       Date:  2018-05-22

Review 5.  Gadolinium deposition and the potential for toxicological sequelae - A literature review of issues surrounding gadolinium-based contrast agents.

Authors:  Kerry A Layne; Paul I Dargan; John R H Archer; David M Wood
Journal:  Br J Clin Pharmacol       Date:  2018-08-17       Impact factor: 4.335

Review 6.  Is MRI imaging in pediatric age totally safe? A critical reprisal.

Authors:  Sergio Salerno; Claudio Granata; Marco Trapenese; Vittorio Cannata; Davide Curione; Maria Camilla Rossi Espagnet; Andrea Magistrelli; Paolo Tomà
Journal:  Radiol Med       Date:  2018-05-03       Impact factor: 3.469

Review 7.  Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers.

Authors:  Jessica Wahsner; Eric M Gale; Aurora Rodríguez-Rodríguez; Peter Caravan
Journal:  Chem Rev       Date:  2018-10-16       Impact factor: 60.622

8.  Positron Emission Tomography-Magnetic Resonance Imaging Pharmacokinetics, In Vivo Biodistribution, and Whole-Body Elimination of Mn-PyC3A.

Authors:  Iris Yuwen Zhou; Ian A Ramsay; Ilknur Ay; Pamela Pantazopoulos; Nicholas J Rotile; Alison Wong; Peter Caravan; Eric M Gale
Journal:  Invest Radiol       Date:  2021-04-01       Impact factor: 10.065

9.  A colorful approach towards developing new nano-based imaging contrast agents for improved cancer detection.

Authors:  Helen R Salinas; Dominie L Miyasato; Olga E Eremina; Rodolfo Perez; Karen L Gonzalez; Alexander T Czaja; Sean Burkitt; Arjun Aron; Augusta Fernando; Lauro S Ojeda; Kimberly N Larson; Ahmed W Mohamed; Jos L Campbell; Beth A Goins; Cristina Zavaleta
Journal:  Biomater Sci       Date:  2020-08-19       Impact factor: 6.843

Review 10.  Important Tools for Use by Pediatric Endocrinologists in the Assessment of Short Stature

Authors:  José I. Labarta; Michael B. Ranke; Mohamad Maghnie; David Martin; Laura Guazzarotti; Roland Pfäffle; Ekaterina Koledova; Jan M. Wit
Journal:  J Clin Res Pediatr Endocrinol       Date:  2020-10-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.